1093 Share Price

Open 8.32 Change Price %
High 8.38 1 Day -0.13 -1.56
Low 8.19 1 Week -0.16 -1.91
Close 8.22 1 Month 0.35 4.45
Volume 15126643 1 Year 0.13 1.61
52 Week High 8.60
52 Week Low 5.92
1093 Important Levels
Resistance 2 8.40
Resistance 1 8.32
Pivot 8.26
Support 1 8.12
Support 2 8.04
HKG HongKong Most Active Stocks
0136 0.57 -17.39%
0261 0.01 0.00%
0566 3.91 0.00%
8173 0.01 -66.67%
0939 5.79 -0.17%
2324 0.06 -14.29%
3988 3.52 -0.56%
1398 4.77 0.42%
0981 1.00 0.00%
0061 0.02 0.00%
More..
HKG HongKong Top Gainers Stocks
0412 0.59 31.11%
8037 0.32 28.00%
0915 3.06 22.40%
0395 0.14 16.67%
8220 0.17 13.33%
8200 0.10 11.11%
8057 2.15 10.26%
0281 0.54 10.20%
3828 1.31 10.08%
8116 0.22 10.00%
More..
HKG HongKong Top Losers Stocks
8173 0.01 -66.67%
8231 0.25 -28.57%
4333 60.00 -25.00%
0136 0.57 -17.39%
8002 4.00 -15.97%
2324 0.06 -14.29%
1555 0.79 -14.13%
8081 0.09 -10.00%
8286 0.54 -10.00%
8201 0.09 -10.00%
More..

CSPC Pharmaceutical Group Ltd (HKG: 1093)

1093 Technical Analysis 4
As on 5th Dec 2016 1093 Share Price closed @ 8.22 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 7.19 & Buy for SHORT-TERM with Stoploss of 8.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
1093 Target for December
1st Target up-side 8.97
2nd Target up-side 9.41
3rd Target up-side 9.86
1st Target down-side 7.69
2nd Target down-side 7.25
3rd Target down-side 6.8
1093 Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website
1093 Address
1093
Interactive Technical Analysis Chart CSPC Pharmaceutical Group Ltd ( 1093 HKG HongKong )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on CSPC Pharmaceutical Group Ltd
1093 Business Profile
CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products. It offers finished drugs, including NBP series primarily for the acute ischemic stroke; Oulaining series primarily for the treatment of mild to moderate memory and mental impairment resulting from vascular dementia, senile dementia, and brain trauma; Xuanning principally for hypertension; Duomeisu, a chemotherapy drug; Jinyouli for the prevention of leucopenia and infection induced by chemotherapy; and Ailineng primarily for the treatment of nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion. The company also provides generic drugs, antibiotics, vitamin C products, and caffeine and other drugs. In addition, it researches and develops approximately 170 products for therapeutic areas of anti-infective, cardio-cerebrovascular, diabetes, neurology, and oncology. Further, the company offers pharmaceutical research and development services; and sewage treatment services. It has operations primarily in the People’s Republic of China, other Asian regions, the Americas, and Europe. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. The company is based in Wan Chai, Hong Kong and is considered a Red Chip company due to its listing on the Hong Kong Stock Exchange.